Tadashi Takeuchi

3.0k total citations · 2 hit papers
50 papers, 2.2k citations indexed

About

Tadashi Takeuchi is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, Tadashi Takeuchi has authored 50 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 13 papers in Oncology and 13 papers in Epidemiology. Recurrent topics in Tadashi Takeuchi's work include Pancreatitis Pathology and Treatment (12 papers), Neuropeptides and Animal Physiology (11 papers) and Neuroendocrine Tumor Research Advances (9 papers). Tadashi Takeuchi is often cited by papers focused on Pancreatitis Pathology and Treatment (12 papers), Neuropeptides and Animal Physiology (11 papers) and Neuroendocrine Tumor Research Advances (9 papers). Tadashi Takeuchi collaborates with scholars based in Japan, United States and Canada. Tadashi Takeuchi's co-authors include Keiko Shiratori, Shinichiro Watanabe, Kenji Yoshida, Chie Kudo‐Saito, Yutaka Kawakami, Fumitake Toki, Naoaki Hayashi, Katsusuke Satake, Hideo Ozaki and Tatsuji Homma and has published in prestigious journals such as The Lancet, Gastroenterology and Cancer Cell.

In The Last Decade

Tadashi Takeuchi

43 papers receiving 2.2k citations

Hit Papers

Chronic pancreatitis caused by an autoimmune abnormality 1995 2026 2005 2015 1995 2009 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tadashi Takeuchi Japan 14 1.2k 970 693 634 501 50 2.2k
Antonio Pellı́n Spain 24 262 0.2× 304 0.3× 411 0.6× 140 0.2× 533 1.1× 65 1.7k
Yoshinobu Hoshii Japan 24 324 0.3× 203 0.2× 237 0.3× 185 0.3× 1.0k 2.1× 94 1.8k
Shinji Osada Japan 21 477 0.4× 78 0.1× 596 0.9× 187 0.3× 332 0.7× 113 1.5k
Makoto Ishikawa Japan 20 265 0.2× 62 0.1× 419 0.6× 487 0.8× 589 1.2× 52 1.7k
J. Pablo Arnoletti United States 28 807 0.7× 68 0.1× 1.3k 1.9× 185 0.3× 537 1.1× 66 2.1k
Jinping Lai United States 24 429 0.4× 62 0.1× 516 0.7× 910 1.4× 856 1.7× 108 2.5k
Marco Siech Germany 22 1.6k 1.3× 46 0.0× 1.9k 2.7× 387 0.6× 533 1.1× 45 2.7k
Jie Zang China 25 330 0.3× 157 0.2× 593 0.9× 209 0.3× 655 1.3× 95 2.0k
Marie‐Pierre Simon France 21 259 0.2× 188 0.2× 429 0.6× 52 0.1× 1.1k 2.1× 31 1.9k
Johan Wejde Sweden 23 166 0.1× 374 0.4× 378 0.5× 50 0.1× 587 1.2× 47 1.5k

Countries citing papers authored by Tadashi Takeuchi

Since Specialization
Citations

This map shows the geographic impact of Tadashi Takeuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadashi Takeuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadashi Takeuchi more than expected).

Fields of papers citing papers by Tadashi Takeuchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tadashi Takeuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadashi Takeuchi. The network helps show where Tadashi Takeuchi may publish in the future.

Co-authorship network of co-authors of Tadashi Takeuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Tadashi Takeuchi. A scholar is included among the top collaborators of Tadashi Takeuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tadashi Takeuchi. Tadashi Takeuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Komaru, Yohei, et al.. (2019). Recurrent cardiovascular events in patients with newly diagnosed acute coronary syndrome: Influence of diabetes and its management with medication. Journal of Diabetes and its Complications. 34(3). 107511–107511. 10 indexed citations
2.
Takeuchi, Tadashi, et al.. (2014). Comparison of cardiovascular disease risk associated with 3 lipid measures in Japanese adults. Journal of clinical lipidology. 8(5). 501–509. 7 indexed citations
3.
Takeuchi, Tadashi. (2009). Tribute to The 40th Anniversary of The Japan Pancreas Society. Suizo. 24(1). 7–11.
4.
Kudo‐Saito, Chie, et al.. (2009). Cancer Metastasis Is Accelerated through Immunosuppression during Snail-Induced EMT of Cancer Cells. Cancer Cell. 15(3). 195–206. 682 indexed citations breakdown →
5.
Satake, Katsusuke & Tadashi Takeuchi. (1994). Comparison of CA19-9 with Other Tumor Markers in the Diagnosis of Cancer of the Pancreas. Pancreas. 9(6). 720–724. 41 indexed citations
6.
Satake, Katsusuke, Tadashi Takeuchi, Tatsuji Homma, & Hideo Ozaki. (1994). CA19-9 as a Screening and Diagnostic Tool in Symptomatic Patients. Pancreas. 9(6). 703–706. 53 indexed citations
7.
Shiratori, Keiko, et al.. (1994). A New CCK-A Antagonist, KSG-504, Administered Intraduodenally, Inhibits Pancreatic Secretion in Rats. Pancreas. 9(2). 225–229. 3 indexed citations
8.
Shiratori, Keiko, Shinichiro Watanabe, & Tadashi Takeuchi. (1993). Role of Gastric Mucosal Prostaglandin E<sub>2</sub> in the Inhibitory Action of Secretin and Somatostatin on Gastric Acid Secretion in the Rat. Digestion. 54(3). 163–167. 3 indexed citations
9.
Shiratori, Keiko, Shinichiro Watanabe, & Tadashi Takeuchi. (1993). Inhibitory Effect of Intraduodenal Administration of Somatostatin Analogue SDZ CO 61 1 on Rat Pancreatic Exocrine Secretion. Pancreas. 8(4). 471–475.
10.
Watanabe, Shinichiro, Tadashi Takeuchi, & William Y. Chey. (1992). Mediation of trypsin inhibitor-induced pancreatic hypersecretion by secretin and cholecystokinin in rats. Gastroenterology. 102(2). 621–628. 27 indexed citations
11.
Shiratori, Keiko, et al.. (1991). Potentiating Effect of CCK and Secretin on Rat Exocrine Pancreas and its Cholinergic Dependence. Pancreas. 6(5). 603–608. 18 indexed citations
12.
Shiratori, Keiko, Shinichiro Watanabe, & Tadashi Takeuchi. (1991). Somatostatin Analog, SMS 201-995, Inhibits Pancreatic Exocrine Secretion and Release of Secretin and Cholecystokinin in Rats. Pancreas. 6(1). 23–30. 16 indexed citations
13.
Aki, Toshihiko, et al.. (1990). A case of 4 synchronous multiple carcinomas of the large intestine after resection of carcinomas of the uterine body and the ovary.. The Japanese Journal of Gastroenterological Surgery. 23(3). 815–819. 1 indexed citations
14.
Shiratori, Keiko, et al.. (1989). Effect of CCK Antagonists CR 1409 and CR 1505 on Rat Pancreatic Exocrine Secretion In Vivo. Pancreas. 4(6). 744–750. 10 indexed citations
15.
Shiratori, Keiko, Shinichiro Watanabe, & Tadashi Takeuchi. (1989). Effect of Fatty Acid on Secretin Release and Cholinergic Dependence of Pancreatic Secretion in Rats. Pancreas. 4(4). 452–458. 6 indexed citations
16.
Shiratori, Keiko, et al.. (1989). Plaunotol Stimulates Endogenous Secretin Release and Exocrine Pancreatic Secretion in Rats. Digestion. 44(3). 142–147. 4 indexed citations
17.
Shiratori, Keiko, et al.. (1989). Effect of Plaunotol on Release of Plasma Secretin and Pancreatic Exocrine Secretion in Humans. Pancreas. 4(3). 323–328. 5 indexed citations
18.
Aozasa, Katsuyuki, A Kurata, Nariaki Matsuura∥, et al.. (1988). Prognostic value of histologic and clinical factors in 56 patients with gastrointestinal lymphomas. Cancer. 61(2). 309–315. 69 indexed citations
19.
Shiratori, Keiko, Shinichiro Watanabe, & Tadashi Takeuchi. (1982). Serum gastrin levels in response to exogenous secretin in patients with duodenal ulcer. Gastroenterologia Japonica. 17(2). 80–86. 2 indexed citations
20.
Takeuchi, Tadashi, et al.. (1959). Congenital Glomerulosclerosis and Pneumonia of Infants. 5(1). 33–40. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026